Agios Pharmaceuticals Inc 2024 Sustainability Report
Company: Agios Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2024
Type: Sustainability Report
Pages: 44
The report describes Agios' patient-centered approach to clinical-trial design and access to medicines, including the RISE UP program and patient support initiatives. It highlights employee inclusion, flexible work, and diversity efforts, alongside 2024 environmental projects to reduce energy use and waste. ESG oversight is provided through an ESG Working Group and regular updates to the Board of Directors.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.